Literature DB >> 23219956

Regenerative activity of the lung after epithelial injury.

Andrew E Vaughan1, Harold A Chapman.   

Abstract

Lung epithelial cells use remarkably adaptive sensing and signaling systems to maintain a physiological state supporting gas exchange and minimizing environmental insults. One facet of epithelial adaptability is the reversible acquisition of mesenchymal features, a process termed epithelial-mesenchymal transition (EMT). Although in the adult, permanent and complete EMT appears rare or non-existent, a growing body of evidence implicates a critical role for the activation of EMT signaling in tissue remodeling, including fibrotic lung disease. The specific phenotypes of cells undergoing EMT re-programming during epithelial responses to injury continue to be defined and are reviewed here. Several recent studies implicate epithelial expression of canonical EMT transcription factors, such as Snail and Twist1, with the acquisition of a less differentiated, more proliferative stem-like state, providing an additional link between activation of EMT signaling and tissue repair. In lung airways, proliferating variant clara cells rely upon Snail for effective epithelial repair, and in the breast, cells possessing the greatest regenerative capacity also express Snail2. The ongoing elucidation of signaling underlying epithelial stem/progenitor expansion coincides with recent discoveries implicating regenerative activity in the lung, possibly including de novo regeneration of airway and alveolar units. It remains largely unknown what signals drive organization of epithelial progenitor cells that expand after lung injury, to what degree such organization is ever functionally relevant, and whether the lung regenerative potential recently observed in mouse models extends to humans. Yet these unknowns with clinical potential bring future mechanistic studies of EMT and lung repair directly into the field of regenerative medicine. This article is part of a Special Issue entitled: Fibrosis: Translation of basic research to human disease.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23219956     DOI: 10.1016/j.bbadis.2012.11.020

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  21 in total

1.  An official American Thoracic Society workshop report: stem cells and cell therapies in lung biology and diseases.

Authors:  Daniel J Weiss; Daniel Chambers; Adam Giangreco; Armand Keating; Darrell Kotton; Peter I Lelkes; Darcy E Wagner; Darwin J Prockop
Journal:  Ann Am Thorac Soc       Date:  2015-04

2.  Activation of type II cells into regenerative stem cell antigen-1(+) cells during alveolar repair.

Authors:  Yuru Liu; Varsha Suresh Kumar; Wei Zhang; Jalees Rehman; Asrar B Malik
Journal:  Am J Respir Cell Mol Biol       Date:  2015-07       Impact factor: 6.914

Review 3.  Plasma membrane wounding and repair in pulmonary diseases.

Authors:  Xiaofei Cong; Rolf D Hubmayr; Changgong Li; Xiaoli Zhao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-01-06       Impact factor: 5.464

4.  Protein Kinase Cζ Inhibitor Promotes Resolution of Bleomycin-Induced Acute Lung Injury.

Authors:  Luis G Vargas Buonfiglio; Mosaab Bagegni; Jennifer A Borcherding; Jessica C Sieren; Juan C Caraballo; Andrew Reger; Joseph Zabner; Xiaopeng Li; Alejandro P Comellas
Journal:  Am J Respir Cell Mol Biol       Date:  2016-12       Impact factor: 6.914

5.  Dynamics of Influenza-induced Lung-Resident Memory T Cells, Anatomically and Functionally Distinct Lung Mesenchymal Populations, and Dampening of Acute Lung Injury by Neutrophil Transfer of Micro-RNA-223 to Lung Epithelial Cells.

Authors:  Keith T Ferguson; Alexandra C McQuattie-Pimentel; Elizabeth S Malsin; Peter H S Sporn
Journal:  Am J Respir Cell Mol Biol       Date:  2018-09       Impact factor: 6.914

6.  Selective gene expression analysis of the neuroepithelial body microenvironment in postnatal lungs with special interest for potential stem cell characteristics.

Authors:  Line Verckist; Robrecht Lembrechts; Sofie Thys; Isabel Pintelon; Jean-Pierre Timmermans; Inge Brouns; Dirk Adriaensen
Journal:  Respir Res       Date:  2017-05-08

7.  Active epithelial Hippo signaling in idiopathic pulmonary fibrosis.

Authors:  Jason J Gokey; Anusha Sridharan; Yan Xu; Jenna Green; Gianni Carraro; Barry R Stripp; Anne-Karina T Perl; Jeffrey A Whitsett
Journal:  JCI Insight       Date:  2018-03-22

8.  MEG3 is increased in idiopathic pulmonary fibrosis and regulates epithelial cell differentiation.

Authors:  Jason J Gokey; John Snowball; Anusha Sridharan; Joseph P Speth; Katharine E Black; Lida P Hariri; Anne-Karina T Perl; Yan Xu; Jeffrey A Whitsett
Journal:  JCI Insight       Date:  2018-09-06

9.  Inhibition of epithelial-to-mesenchymal transition and pulmonary fibrosis by methacycline.

Authors:  Ying Xi; Kevin Tan; Alexis N Brumwell; Steven C Chen; Yong-Hyun Kim; Thomas J Kim; Ying Wei; Harold A Chapman
Journal:  Am J Respir Cell Mol Biol       Date:  2014-01       Impact factor: 6.914

10.  Distinct Chronic Post-Viral Lung Diseases upon Infection with Influenza or Parainfluenza Viruses Differentially Impact Superinfection Outcome.

Authors:  Geyon L Garcia; Alex Valenzuela; Tomaz Manzoni; Andrew E Vaughan; Carolina B López
Journal:  Am J Pathol       Date:  2019-12-19       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.